|
Volumn 70, Issue 2, 2014, Pages
|
Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33%
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BRIMONIDINE;
CLONAZEPAM;
FOLIC ACID;
INFLIXIMAB;
METHOTREXATE;
TRAZODONE;
VENLAFAXINE;
ZOLPIDEM;
GEL;
QUINOXALINE DERIVATIVE;
ADULT;
ANXIETY;
ANXIETY DISORDER;
BURNING SENSATION;
CASE REPORT;
CHEEK;
CHIN;
DRUG WITHDRAWAL;
ERYTHEMA;
FACE EDEMA;
FEMALE;
FLUSHING;
FOREHEAD;
GEL;
HASHIMOTO DISEASE;
HUMAN;
LETTER;
NOSE;
PRIORITY JOURNAL;
PSORIASIS;
ROSACEA;
SKIN BURNING SENSATION;
URTICARIA;
YOUNG ADULT;
CHEMICALLY INDUCED;
DOSE RESPONSE;
DRUG ADMINISTRATION;
EPIDEMIOLOGY;
FOLLOW UP;
INTRADERMAL DRUG ADMINISTRATION;
PAIN;
PATHOPHYSIOLOGY;
RECURRENT DISEASE;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
THERAPEUTIC USE;
ADMINISTRATION, CUTANEOUS;
ADULT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
ERYTHEMA;
FEMALE;
FOLLOW-UP STUDIES;
GELS;
HUMANS;
PAIN;
QUINOXALINES;
RECURRENCE;
RISK ASSESSMENT;
ROSACEA;
SAMPLING STUDIES;
SEVERITY OF ILLNESS INDEX;
|
EID: 84892636148
PISSN: 01909622
EISSN: 10976787
Source Type: Journal
DOI: 10.1016/j.jaad.2013.10.054 Document Type: Article |
Times cited : (40)
|
References (4)
|